SouthState’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
SouthState's UTHR Position: Q3 2026 in Review
SouthState reduced its United Therapeutics (UTHR) stake by 50% in Q3 2026, selling an estimated $517 and leaving 1 share worth $542. The position accounts for ﹤0.01% of the portfolio, ranked #1251.
SouthState first reported a position in UTHR in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.85K in Q1 2025. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- SouthState held 1 share of United Therapeutics worth $542 as of Q3 2026.
- SouthState sold 1 United Therapeutics share in Q3 2026, an estimated $517.
- United Therapeutics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1251 holding.
- SouthState first reported a position in United Therapeutics in Q1 2025 and has held it in 7 quarters since.
- SouthState's United Therapeutics position peaked at $1.85K in Q1 2025.
- 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.